Europe - Euronext Milan - BIT:1MRK - DE0006599905 - Common Stock
The current stock price of 1MRK.MI is 118.95 EUR. In the past month the price decreased by -18.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.84 | 200.10B | ||
| 1SAN.MI | SANOFI | 10.75 | 198.47B | ||
| SAN.PA | SANOFI | 10.74 | 198.23B | ||
| MRK.DE | MERCK KGAA | 14.13 | 52.41B | ||
| UNC.DE | UCB SA | 37.51 | 46.84B | ||
| UCB.BR | UCB SA | 36.68 | 45.81B | ||
| BAYN.DE | BAYER AG-REG | 6.73 | 35.31B | ||
| 1BAYN.MI | BAYER AG-REG | 6.65 | 34.87B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.71 | 10.18B | ||
| IPN.PA | IPSEN | 11.68 | 10.06B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.48 | 9.30B | ||
| VIRP.PA | VIRBAC SA | 20.3 | 2.95B |
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 63,160 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
MERCK KGAA
Frankfurter Strasse 250
Darmstadt HESSEN DE
Employees: 63160
Phone: 496151720
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 63,160 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
The current stock price of 1MRK.MI is 118.95 EUR. The price increased by 5.31% in the last trading session.
MERCK KGAA (1MRK.MI) has a dividend yield of 1.99%. The yearly dividend amount is currently 0.65.
1MRK.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
1MRK.MI stock is listed on the Euronext Milan exchange.
24 analysts have analysed 1MRK.MI and the average price target is 144.63 EUR. This implies a price increase of 21.58% is expected in the next year compared to the current price of 118.95.
MERCK KGAA (1MRK.MI) currently has 63160 employees.
ChartMill assigns a technical rating of 2 / 10 to 1MRK.MI.
ChartMill assigns a fundamental rating of 4 / 10 to 1MRK.MI. 1MRK.MI has an average financial health and profitability rating.
Over the last trailing twelve months 1MRK.MI reported a non-GAAP Earnings per Share(EPS) of 8.53. The EPS increased by 1.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.49% | ||
| ROA | 6.04% | ||
| ROE | 10.13% | ||
| Debt/Equity | 0.22 |
24 analysts have analysed 1MRK.MI and the average price target is 144.63 EUR. This implies a price increase of 21.58% is expected in the next year compared to the current price of 118.95.
For the next year, analysts expect an EPS growth of -1.79% and a revenue growth 0.28% for 1MRK.MI